Bicycle Therapeutics (BCYC) Cash from Operations: 2018-2025
Historic Cash from Operations for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to -$71.2 million.
- Bicycle Therapeutics' Cash from Operations fell 78.68% to -$71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$239.7 million, marking a year-over-year decrease of 18.31%. This contributed to the annual value of -$164.7 million for FY2024, which is 171.70% down from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Cash from Operations is -$71.2 million, which was up 2.22% from -$72.8 million recorded in Q2 2025.
- Over the past 5 years, Bicycle Therapeutics' Cash from Operations peaked at $34.1 million during Q2 2023, and registered a low of -$86.4 million during Q1 2025.
- Over the past 3 years, Bicycle Therapeutics' median Cash from Operations value was -$46.4 million (recorded in 2023), while the average stood at -$41.4 million.
- Per our database at Business Quant, Bicycle Therapeutics' Cash from Operations spiked by 317.51% in 2021 and then slumped by 3,786.05% in 2024.
- Bicycle Therapeutics' Cash from Operations (Quarterly) stood at -$10.4 million in 2021, then tumbled by 190.46% to -$30.3 million in 2022, then plummeted by 56.02% to -$47.3 million in 2023, then soared by 80.13% to -$9.4 million in 2024, then plummeted by 78.68% to -$71.2 million in 2025.
- Its Cash from Operations stands at -$71.2 million for Q3 2025, versus -$72.8 million for Q2 2025 and -$86.4 million for Q1 2025.